List Info

Thread: Re: SCOAP3




Re: SCOAP3
country flaguser name
United States
2007-12-07 17:45:04
We want to think Fred Friend, Travis Brooks, and Michael
Fosmire 
(the latter two on PAMNET) for their thoughtful replies to
our 
previous post, and to comment briefly on some of the issues
that 
they have raised.

Fred states that "the risk from a SCOAP3 model is no
greater and 
arguably less than under the present model."  While we
appreciate 
his emphasis on the strengths of an international
consortium, we 
think that he underestimates one crucial difference between

subscription models and SCOAP3: in the former if one does
not pay 
for a subscription one no longer has access to the journals,

while in the latter non-payment has no immediate
consequence. 
We think that lack of access to a journal as important as
PRD 
provides a strong deterrent to non-payment, at least in 
institutions with major HEP research efforts.

Michael says "This is one reason APS has introduced
tiered 
pricing...to slow the loss of subscriptions from smaller 
institutions...and I think by and large the research
institutions 
accept and support the fact that they are already bearing
the 
brunt of the costs of publication."  While Michael is
correct 
that major research institutions deserve credit for
accepting 
higher subscription prices in order to keep APS journals 
accessible to smaller institutions, he is not correct in 
suggesting that major research institutions currently bear
the 
brunt of publication costs for APS journals.  In fact, APS
tiered 
pricing has been remarkably successful in maintaining our
small 
subscribers, with the result that almost half of the US 
subscription revenue for PRD comes from approximately 200 
subscriptions at APS Tier 1 and 2 institutions (the smallest
and 
least research-intensive places).  This very surprising fact
has 
major implications both for the start- up funding of SCOAP3
and 
for the challenge of recovering should SCOAP3 fail.

Finally, while we agree with Michael that our own small OA 
journals, and especially PRST- AB, provide an interesting
test 
for the SCOAP3 model, we also want to emphasize the need for

caution when interpreting such experiments, because of the 
uncertainties with allocating various overhead costs to a
small 
journal operating under the umbrella of a much larger
publishing 
enterprise.  Nevertheless, using our best judgment of these

allocated costs, we find that despite steady and generous
support 
from the accelerator community, PRST- AB has never run in
the 
black.  There are many possible explanations for this result

(e.g., perhaps we have not been sufficiently aggressive in 
seeking support), and one obviously should be careful about

extrapolating results from small experiments.

Gene D. Sprouse
Editor-  in-  Chief, American Physical Society

Joseph W. Serene
Treasurer and Publisher, American Physical Society

>>> ""FrederickFriend""
<ucylfjfucl.ac.uk> 12/05/07 7:45 PM >>>

I applaud the willingness of APS to support the SCOAP3
initiative 
if the right conditions are met. This new model could
provide 
better value for the academic community and a successful new

business model for academic publishers. Gene Sprouse is
right to 
point to the risk that "some libraries might divert
their now 
voluntary contributions from SCOAP3 to more pressing
needs", but 
that risk is already there and is already damaging the
income of 
some learned societies. Some libraries are diverting funds
from 
individual journal subscriptions in order to maintain
"big deals" 
with the major commercial publishers.

The risk from a SCOAP3 model is no greater and arguably less
than 
under the present model. The strength in the SCOAP3 model to

counter the risk comes from the international nature of the

alliance between funding organizations and libraries, a
strength 
which will be greater than that in the present model, in
which 
financial support for journals comes primarily from the
library 
sector and on a national rather than an international
basis.

Fred Friend
JISC Scholarly Communication Consultant
Honorary Director Scholarly Communication UCL


[1]

about | contact  Other archives ( Real Estate discussion Medical topics )